2012: Year in review
Recent articles
What stood out to you in 2012?
We packaged the year’s research highlights from our vantage point. What advances stood out to you in 2012? And where do you see the field going?
What stood out to you in 2012?
We packaged the year’s research highlights from our vantage point. What advances stood out to you in 2012? And where do you see the field going?
Top tools and techniques of 2012
2012 saw many new exciting — and often colorful — technical advances, ranging from tools that build brains from the cell up to robots that can replace neuroscientists.
Top tools and techniques of 2012
2012 saw many new exciting — and often colorful — technical advances, ranging from tools that build brains from the cell up to robots that can replace neuroscientists.
Drugs in development for autism
A look at various drugs attempting to address autism and their stages of development.
Drugs in development for autism
A look at various drugs attempting to address autism and their stages of development.
Predictions for 2013
Take a look through SFARI.org’s crystal ball to predict major developments in autism research in 2013.
Predictions for 2013
Take a look through SFARI.org’s crystal ball to predict major developments in autism research in 2013.
Most-viewed articles of 2012
A list of the ten stories that most caught our readers’ attention this year.
Most-viewed articles of 2012
A list of the ten stories that most caught our readers’ attention this year.
Hot topics in 2012
New candidate genes, drugs in development and diagnostic debates were just a few of the themes that garnered intense interest this year.
Hot topics in 2012
New candidate genes, drugs in development and diagnostic debates were just a few of the themes that garnered intense interest this year.
Director’s column: 2012 in review
SFARI director Gerald Fischbach comments on the year’s most notable papers.
Director’s column: 2012 in review
SFARI director Gerald Fischbach comments on the year’s most notable papers.
Notable papers of 2012
Among a wealth of exciting research, ten sets of papers made an impact this year.
Notable papers of 2012
Among a wealth of exciting research, ten sets of papers made an impact this year.
Explore more from The Transmitter
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
‘Friction-maxxing’ in school: Students should read primary literature, not AI summaries
Trainees need to learn how to identify a neuroscience paper’s major takeaways and integrate them into their understanding. This skill doesn’t come from outsourcing the work to large language models.
‘Friction-maxxing’ in school: Students should read primary literature, not AI summaries
Trainees need to learn how to identify a neuroscience paper’s major takeaways and integrate them into their understanding. This skill doesn’t come from outsourcing the work to large language models.